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OBJECTIVES: Precise evaluation of the level of liver fibrosis is recommended in
patients with chronic hepatitis C (CHC). Blood fibrosis tests and Fibroscan are now
widely used for the non-invasive diagnosis of liver fibrosis. Detailed fibrosis stage
classifications have been developed to provide an estimation of the liver fibrosis
stage from the results of these non-invasive tests. Our aim was to develop a new and
more accurate fibrosis stage classification by using new scores combining non-
invasive fibrosis tests.METHODS: In all, 729 patients with CHC (exploratory set:
349; validation set: 380) had liver biopsy for Metavir fibrosis (F) staging, and 6
fibrosis tests: Fibroscan, Fibrotest, FibroMeter, Hepascore, FIB-4, APRI. RESULTS:
Exploratory set: Fibroscan and FibroMeter were the independent predictors of
different diagnostic targets of liver fibrosis. New fibrosis indexes combining
FibroMeter and Fibroscan were thus developed for the diagnosis of clinically
significant fibrosis (CSF-index) or severe fibrosis (SF-index). The association of CSF-
and SF-indexes provided a new fibrosis stage classification (CSF/SF classification):
F0/1, F1/2, F2±1, F2/3, F3±1, F4. Validation set: CSF/SF classification had a high
diagnostic accuracy (85.8% well-classified patients), significantly higher than the
diagnostic accuracies of FibroMeter (69.7%, P<0.001), Fibroscan (63.3%, P<0.001),
or Fibrotest (43.9%, P<0.001) classifications. CONCLUSIONS: The association of
new fibrosis indexes combining FibroMeter and Fibroscan provides a new fibrosis
stage classification. This classification is significantly more accurate than Fibrotest,
FibroMeter, or Fibroscan classifications, and improves the accuracy of the non-
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